Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
The field of pain management has much to offer besides drugs...
Researchers say given the many associated downsides and risks, opioids should not be a first choice for chronic noncancer pain.
Living with chronic pain not only drags down quality of life, but it is also linked to poorer HIV-related health outcomes.
Aspirin is an effective pain reliever, but taking it comes with potential risks as well as benefits.
An alarmingly high proportion of the HIV population is apparently at risk of prescription pill–driven opioid addiction.
Between 39 and 85 percent of the HIV population experiences chronic pain.
Probuphine promises to deliver six months of continuous buprenorphine treatment. What does this mean for the future of the opioid epidemic?
It’s a challenge for some people with HIV. But there’s help for conquering—or at least managing—chronic pain.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.